Table 2.
Baseline characteristics of propensity-matched patients n (%)
| Characteristic | Group A | Group B |
| (n = 24) | (n = 24) | |
| Sex | ||
| Male | 22 (91.7) | 23 (95.8) |
| Female | 2 (8.3) | 1 (4.2) |
| Age | ||
| ≥ 55 yr | 14 (58.3) | 9 (37.5) |
| < 55 yr | 10 (41.7) | 15 (62.5) |
| Type of tumor | ||
| Nodular | 21 (87.5) | 22 (91.7) |
| Infiltrative | 3 (12.5) | 2 (8.3) |
| HCC maximum diameter | ||
| ≥ 5 cm | 16 (66.7) | 17 (70.8) |
| < 5 cm | 8 (33.3) | 7 (29.2) |
| Degree of MPVTT | ||
| Stenosis | 21 (87.5) | 19 (79.2) |
| Occlusive | 3 (12.5) | 5 (20.8) |
| Child-pugh class | ||
| A | 20 (83.3) | 21 (87.5) |
| B | 4 (16.7) | 3 (12.5) |
| ECOG performance status | ||
| 0/1 | 20(83.3) | 22(91.7) |
| 2 | 4(16.7) | 2(8.3) |
| Etiology of liver disease | ||
| HBV | 22 (91.7) | 23 (87.5) |
| Other | 2 (8.3) | 1 (12.5) |
| Serum AFP level | ||
| ≥ 400 | 12 (50.0) | 10 (41.7) |
| < 400 | 12 (50.0) | 14 (58.3) |
| Extrahepatic metastasis | 1 (3.8) | 3 (11.5) |
AFP: Alfa-fetoprotein; ECOG: Eastern cooperative oncology group; HBV: Hepatitis B virus; MPVTT: Main portal vein tumor thrombus; HCC: Hepatocellular carcinoma.